Skip to main content

Table 2 C-reactive protein (CRP) and procalcitonin (PCT) values in the acute and convalescent phases of acute Q fever, scrub typhus, and murine typhus

From: Serum C-reactive protein and procalcitonin values in acute Q fever, scrub typhus, and murine typhus

 

Acute Q fever (n = 115)

Scrub typhus (n = 55)

Murine typhus (n = 19)

All (n = 189)

p

CRP (mg/L)

 Acute phase

Mean ± SD

80.6 ± 60.9

74.2 ± 66.8

75.0 ± 74.2

78.2 ± 63.7

0.824

> 25

78.5% (84/107)

74.5% (38/51)

72.2% (13/18)

76.7% (135/176)

0.766

> 50

68.2% (73/107)

58.8% (30/51)

50.0% (9/18)

63.6% (112/176)

0.231

> 75

45.8% (49/107)

37.3% (19/51)

38.9% (7/18)

42.6% (75/176)

0.564

> 100

33.6% (36/107)

25.5% (13/51)

27.8% (5/18)

30.7% (54/176)

0.560

> 150

11.2% (12/107)

9.8% (5/51)

11.1% (2/18)

10.8% (19/176)

1.000

> 200

3.7% (4/107)

3.9% (2/51)

5.6% (1/18)

4.0% (7/176)

0.853

 Convalescent phasea

Mean ± SD

8.9 ± 25.7

7.3 ± 19.2

4.8 ± 10.6

8.0 ± 22.4

0.827

> 25

4.8% (3/62)

11.1% (4/36)

8.3% (1/12)

7.3% (8/110)

0.476

> 50

4.8% (3/62)

8.3% (3/36)

0% (0/12)

5.5% (6/110)

0.702

> 75

3.2% (2/62)

2.8% (1/36)

0% (0/12)

2.7% (3/110)

1.000

> 100

1.6% (1/62)

0% (0/36)

0% (0/12)

0.9% (1/110)

1.000

PCT (ng/mL)

 Acute phase

Mean ± SD

1.09 ± 1.40

0.99 ± 1.46

0.97 ± 1.22

1.05 ± 1.40

0.904

> 0.25

75.3% (70/93)

63.3% (31/49)

61.5% (8/13)

70.3% (109/155)

0.254

> 0.5

54.8% (51/93)

40.8% (20/49)

46.2% (6/13)

49.7% (77/155)

0.273

> 1.0

31.2% (29/93)

24.5% (12/49)

38.5% (5/13)

29.7% (46/155)

0.545

> 1.5

21.5% (20/93)

22.4% (11/49)

15.4% (2/13)

21.3% (33/155)

0.955

> 2.0

14.0% (13/93)

16.3% (8/49)

7.7% (1/13)

14.2% (22/155)

0.825

> 4.0

6.5% (6/93)

4.1% (2/49)

7.7% (1/13)

5.8% (9/155)

0.764

 Convalescent phasea

Mean ± SD

0.09 ± 0.13

0.29 ± 0.98

0.27 ± 0.73

0.17 ± 0.60

0.209

> 0.25

14.3% (10/70)

13.5% (5/37)

16.7% (2/12)

14.3% (17/119)

1.000

> 0.5

1.4% (1/70)

13.5% (5/37)

8.3% (1/12)

5.9% (7/119)

0.030

> 1.0

0% (0/70)

5.4% (2/37)

8.3% (1/12)

2.5% (3/119)

0.084

> 1.5

0% (0/70)

5.4% (2/37)

8.3% (1/12)

2.5% (3/119)

0.084

> 2.0

0% (0/70)

5.4% (2/37)

8.3% (1/12)

2.5% (3/119)

0.084

  1. SD standard deviation
  2. aTests for the convalescent phase were performed 11–45 days from the disease onset (average, 20.2 ± 5.5 days; median, 19 days)